Doctors and drug companies: is the dangerous liaison drawing to an end? | NOVA. The University of Newcastle's Digital Repository

Home

Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.13/806620

Title: Doctors and drug companies: is the dangerous liaison drawing to an end?
Author/Creator: Moynihan, Ray
Institution: The University of Newcastle. Faculty of Health, School of Medicine and Public Health
Description: The Introduction and Overview will contain a bold statement of the essay themes. Next the section on Entanglement will look at the many forms of doctor-drug company relationships, and the evidence for how these can distort practice. Selling Sickness will briefly explore the way doctor-drug company relationships are important to the widening of boundaries of treatable illness. And finally, Disclosure to Disentanglement will look at self-regulatory and statutory attempts around the world to get more independence in the relationship between doctors and drug companies.
Relation: Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen Vol. 103, Issue 3, p. 141-148
Publisher Link: http://dx.doi.org/10.1016/j.zefq.2009.03.022
Date: 2009
Publisher: Elsevier
Keyword(s): conflict of interests; medicalisation; pharmaceutical industry; key opinion leaders; disease mongering; continuing medical education; CME
Resource Type: journal article
Identifier: http://hdl.handle.net/1959.13/806620
Identifier: ISSN:1865-9217

9 Visitors

11 Hits

NOVA. The University of Newcastle's Digital Repository